Four-year follow-up of patients with imatinib-resistant or intolerant chronic myeloid leukemia receiving dasatinib: efficacy and safety
Huang, Xiaojun, Jiang, Qian, Hu, Jianda, Li, Jianyong, Jin, Jie, Meng, Fanyi, Shen, Zhixiang, Liu, Ting, Wu, Depei, Wang, Jianmin, Wang, JianxiangLanguage:
english
Journal:
Frontiers of Medicine
DOI:
10.1007/s11684-018-0639-7
Date:
August, 2018
File:
PDF, 297 KB
english, 2018